KMC
ELGX

Kirr Marbach & Co’s Endologix Inc ELGX Stock Holding History

Kirr Marbach & Co’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,150
Closed -$147K – 76
2016
Q3 		$147K Hold
1,150
– – 0.03% 69
2016
Q2 		$143K Hold
1,150
– – 0.03% 69
2016
Q1 		$96K Buy
1,150
+150
+15% +$12.4K 0.02% 69
2015
Q4 		$99K Buy
+1,000
New +$107K 0.02% 61

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Kirr Marbach & Co's ELGX Position: Q4 2016 in Review

Kirr Marbach & Co sold out of Endologix Inc (ELGX) in Q4 2016, closing a stake of 1,150 shares — an estimated $147K sold.

Kirr Marbach & Co first reported a position in ELGX in Q4 2015 and held it in 4 quarters. The position peaked at $147K in Q3 2016. 140 funds tracked by Wall St. Rank hold ELGX as of Q4 2016.

  • Kirr Marbach & Co reported no remaining Endologix Inc position as of Q4 2016 after selling out during the quarter.
  • Kirr Marbach & Co sold 1,150 Endologix Inc shares in Q4 2016, an estimated $147K.
  • Kirr Marbach & Co first reported a position in Endologix Inc in Q4 2015 and held it in 4 quarters.
  • Kirr Marbach & Co's Endologix Inc position peaked at $147K in Q3 2016.
  • 140 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2016.

Based on Kirr Marbach & Co's 13F filing for Q4 2016, filed 24 Jan 2017.